Evaluation of Smartphone Versions of VAS and NRS for Use in Adults
Launched by UNIVERSITY OF BRITISH COLUMBIA · Oct 23, 2019
Trial Information
Current as of June 02, 2025
Completed
Keywords
ClinConnect Summary
1. Purpose:
The purpose of this study is to establish whether the Panda versions of the 100mm VAS (Visual Analogue Scale) and NRS-11 (Numeric Rating Scale) agree adequately with and can therefore be used in lieu of already validated paper versions of these scales for the evaluation of post-operative pain in adults. The Panda versions of the pain assessment scales have been condensed in size onto an iPod Touch screen but otherwise appear the same as traditional paper versions.
2. Hypothesis:
There are no significant differences in the failure rates in obtaining pain scores and the pa...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 19 to 75
- • ASA status I-III
- • Undergoing a procedure with anticipated post-surgical pain
- Exclusion Criteria:
- • Undergoing eye surgery
- • Significant cognitive impairment or neurological injury
- • Psychomotor dysfunction
- • Visual impairment
- • Admission to the Intensive Care Unit.
About University Of British Columbia
The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vancouver, British Columbia, Canada
Vancouver, British Columbia, Canada
Patients applied
Trial Officials
Cynthia Yarnold, MD
Principal Investigator
Providence Health & Services
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials